Samsung Biologics and European pharma company enter major manufacturing deal
By Larissa Warneck-Silvestrin
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News
Bio developments
More→
Promising early Parkinson’s immunotherapy results for AC Immune
By Helen Albert
Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years
By Clara Rodriguez Fernandez
Promotional features
More→
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Paid for and content provided by Scorpius BioManufacturing
Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials
Paid for and in partnership with Thermo Fisher Scientific - Biosciences
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
Paid for and content provided by Just – Evotec Biologics
AAVs – liquid treasure handled safely
Paid for and content provided by Single Use Support
Biopharma culture
More→
An overview of the biosimilars space
By Clara Rodriguez Fernandez
The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59
By Larissa Worneck-Silvestrin
Innovations in mass spectrometry accelerate the shift toward precision medicine
By Clara Rodriguez Fernandez
Contract manufacturing & logistics
More→
Markets & regulation
More→
FDA approves first-ever gene therapy to be directly administered to the brain
By Clara Rodriguez Fernandez
AstraZeneca’s rare disease therapy Fasenra receives EU approval
By Clara Rodriguez Fernandez
Mergers & deals
More→
